Accumulation of amyloid-β in the cerebellar cortex of essential tremor patients

[1]  A. Rajput,et al.  Increased LINGO1 in the cerebellum of essential tremor patients , 2014, Movement disorders : official journal of the Movement Disorder Society.

[2]  E. Louis,et al.  Purkinje cell loss in essential tremor , 2014, Movement disorders : official journal of the Movement Disorder Society.

[3]  E. Louis.  Understanding Essential Tremor: Progress on the Biological Front , 2014, Current Neurology and Neuroscience Reports.

[4]  B. P. Warrenburg,et al.  Cognitive impairment in “Other” movement disorders: Hidden defects and valuable clues , 2014, Movement disorders : official journal of the Movement Disorder Society.

[5]  H. Shill,et al.  Essential tremor is not associated with cerebellar Purkinje cell loss , 2014, Movement disorders : official journal of the Movement Disorder Society.

[6]  S. Leurgans,et al.  Disentangling the effects of age and APOE on neuropathology and late life cognitive decline , 2014, Neurobiology of Aging.

[7]  C. Jack,et al.  Biomarker Modeling of Alzheimer’s Disease , 2013, Neuron.

[8]  E. Louis.  ‘Essential Tremor' or ‘the Essential Tremors': Is This One Disease or a Family of Diseases? , 2013, Neuroepidemiology.

[9]  J. Vonsattel,et al.  Quantification of cerebellar hemispheric purkinje cell linear density: 32 ET cases versus 16 controls , 2013, Movement disorders : official journal of the Movement Disorder Society.

[10]  J. Trojanowski,et al.  Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies , 2013, Nature Reviews Neuroscience.

[11]  E. Louis,et al.  The cognitive side of essential tremor: what are the therapeutic implications? , 2013, Therapeutic advances in neurological disorders.

[12]  David A Bennett,et al.  Brain amyloid-β oligomers in ageing and Alzheimer's disease. , 2013, Brain : a journal of neurology.

[13]  D. Sulzer,et al.  Lingo-1 expression is increased in essential tremor cerebellum and is present in the basket cell pinceau , 2013, Acta Neuropathologica.

[14]  Antonio Cerasa,et al.  Neuroimaging of Essential Tremor: What is the Evidence for Cerebellar Involvement? , 2012, Tremor and other hyperkinetic movements.

[15]  G. Deuschl,et al.  An update on tremors. , 2012, Current opinion in neurology.

[16]  Olivier Salvado,et al.  Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. , 2012, Brain : a journal of neurology.

[17]  J. Schneider,et al.  Overview and findings from the religious orders study. , 2012, Current Alzheimer research.

[18]  R. Bharath,et al.  Decrease in Cerebral and Cerebellar Gray Matter in Essential Tremor: A Voxel‐Based Morphometric Analysis under 3T MRI , 2012, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[19]  J. Vonsattel,et al.  Neurofilament protein levels: Quantitative analysis in essential tremor cerebellar cortex , 2012, Neuroscience Letters.

[20]  A. Rajput,et al.  Essential tremor is not dependent upon cerebellar Purkinje cell loss. , 2012, Parkinsonism & related disorders.

[21]  K. Jellinger,et al.  Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature , 2012, Journal of neuropathology and experimental neurology.

[22]  Sean M. Riordan,et al.  Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody , 2012, Molecular Neurodegeneration.

[23]  E. Tan,et al.  LINGO-1 and Neurodegeneration: Pathophysiologic Clues for Essential Tremor , 2012, Tremor and other hyperkinetic movements.

[24]  John L. Robinson,et al.  Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old. , 2011, Brain : a journal of neurology.

[25]  J. Benito-León,et al.  Update on essential tremor. , 2011, Minerva medica.

[26]  H. Pant,et al.  Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  D. Bennett,et al.  Accumulation of Transactive Response DNA Binding Protein 43 in Mild Cognitive Impairment and Alzheimer Disease , 2011, Journal of neuropathology and experimental neurology.

[28]  B. Strooper,et al.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.

[29]  D. Selkoe,et al.  Resolving controversies on the path to Alzheimer's therapeutics , 2011, Nature Medicine.

[30]  Xiongwei Zhu,et al.  Neurofilamentopathy in Neurodegenerative Diseases , 2011, The open neurology journal.

[31]  Elan D. Louis,et al.  Association between Essential Tremor and Other Neurodegenerative Diseases: What Is the Epidemiological Evidence , 2011, Neuroepidemiology.

[32]  F. Lopera,et al.  Deposition of Hyperphosphorylated Tau in Cerebellum of PS1 E280A Alzheimer's Disease , 2011, Brain pathology.

[33]  P. Wong,et al.  Amyloid precursor protein processing and Alzheimer's disease. , 2011, Annual review of neuroscience.

[34]  P. Kempster,et al.  A practical guide to the differential diagnosis of tremor , 2011, Postgraduate Medical Journal.

[35]  Susan M Resnick,et al.  Longitudinal patterns of β-amyloid deposition in nondemented older adults. , 2011, Archives of neurology.

[36]  F. Bermejo-Pareja,et al.  Essential tremor—a neurodegenerative disorder associated with cognitive defects? , 2011, Nature Reviews Neurology.

[37]  J. Benito‐León.  Essential Tremor: One of the Most Common Neurodegenerative Diseases? , 2011, Neuroepidemiology.

[38]  C. Rowe,et al.  Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease , 2011, Annals of neurology.

[39]  J. Morris,et al.  Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease , 2010, Science.

[40]  M. Strong,et al.  Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF‐M/H) in Alzheimer's disease by iTRAQ , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[41]  B. Ritz,et al.  Familial associations of Alzheimer disease and essential tremor with Parkinson disease , 2010, European journal of neurology.

[42]  Elan D Louis,et al.  Essential tremor: evolving clinicopathological concepts in an era of intensive post-mortem enquiry , 2010, The Lancet Neurology.

[43]  K. Blennow,et al.  Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer’s disease , 2010, Acta Neuropathologica.

[44]  J. Benito-León,et al.  Brain structural changes in essential tremor: Voxel-based morphometry at 3-Tesla , 2009, Journal of the Neurological Sciences.

[45]  Elan D Louis,et al.  Essential tremors: a family of neurodegenerative disorders? , 2009, Archives of neurology.

[46]  N. Schupf,et al.  Essential tremor is associated with dementia , 2009, Neurology.

[47]  C. Jack,et al.  Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease , 2009, Brain : a journal of neurology.

[48]  D. Bennett,et al.  Sirtuin 1 Reduction Parallels the Accumulation of Tau in Alzheimer Disease , 2009, Journal of neuropathology and experimental neurology.

[49]  J. Benito-León,et al.  Risk of incident Parkinson’s disease and parkinsonism in essential tremor: a population based study , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[50]  Jeffrey A. James,et al.  Frequent amyloid deposition without significant cognitive impairment among the elderly. , 2008, Archives of neurology.

[51]  F. Calon,et al.  Decreased drebrin mRNA expression in Alzheimer disease: Correlation with tau pathology , 2008, Journal of neuroscience research.

[52]  M. Albert,et al.  Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study. , 2008, Archives of neurology.

[53]  E. Tan,et al.  Evidence of increased odds of essential tremor in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[54]  H. Shill,et al.  Pathologic findings in prospectively ascertained essential tremor subjects , 2008, Neurology.

[55]  P. S. St George-Hyslop,et al.  The in Vivo Brain Interactome of the Amyloid Precursor Protein*S , 2008, Molecular & Cellular Proteomics.

[56]  K. Lyons,et al.  Neuropathological changes in essential tremor: 33 cases compared with 21 controls. , 2007, Brain : a journal of neurology.

[57]  D. Schaid,et al.  Increased risk of essential tremor in first‐degree relatives of patients with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[58]  J. Benito-León,et al.  Risk of incident dementia in essential tremor: A population‐based study , 2007, Movement disorders : official journal of the Movement Disorder Society.

[59]  S. Leurgans,et al.  Cortical biochemistry in MCI and Alzheimer disease , 2007, Neurology.

[60]  C. van Broeckhoven,et al.  Mean age‐of‐onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40 , 2006, Human mutation.

[61]  E D Louis,et al.  Neuropathologic findings in essential tremor , 2006, Neurology.

[62]  J. Benito-León,et al.  Elderly-onset essential tremor is associated with dementia , 2006, Neurology.

[63]  A. Petzold.  Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss , 2005, Journal of the Neurological Sciences.

[64]  Yama Akbari,et al.  Age- and region-dependent alterations in Aβ-degrading enzymes: implications for Aβ-induced disorders , 2005, Neurobiology of Aging.

[65]  R. Martins,et al.  Protein markers for Alzheimer disease in the frontal cortex and cerebellum , 2004, Neurology.

[66]  M. Albert,et al.  Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain , 2004, Neurology.

[67]  A. Rajput,et al.  Essential tremor course and disability , 2004, Neurology.

[68]  J. Morrison,et al.  Progressive degeneration of nonphosphorylated neurofilament protein‐enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: Stereologic analysis of prefrontal cortex area 9 , 2003, The Journal of comparative neurology.

[69]  T. Bird,et al.  Niemann-Pick Disease Type C Yields Possible Clue for Why Cerebellar Neurons Do Not Form Neurofibrillary Tangles , 2002, Neurobiology of Disease.

[70]  M. D'Andrea,et al.  Cerebellar diffuse amyloid plaques are derived from dendritic Aβ42 accumulations in Purkinje cells , 2002, Neurobiology of Aging.

[71]  K. Davis,et al.  Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. , 2000, JAMA.

[72]  C. Masters,et al.  Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease , 1999, Annals of neurology.

[73]  C. Hock,et al.  ELISA-Quantitation of Phosphorylated Tau Protein in the Alzheimer’s Disease Brain , 1999, European Neurology.

[74]  L. Lue,et al.  Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer’s Disease , 1999 .

[75]  J. Trojanowski,et al.  The Levels of Soluble versus Insoluble Brain Aβ Distinguish Alzheimer's Disease from Normal and Pathologic Aging , 1999, Experimental Neurology.

[76]  Martin N Rossor,et al.  Cerebellar pathology in sporadic and familial Alzheimer's disease including APP 717 (Val→Ile) mutation cases: A morphometric investigation , 1996, Journal of the Neurological Sciences.

[77]  Kenneth S. Kosik,et al.  The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology , 1996, Nature Medicine.

[78]  D. Mann,et al.  Diffuse Plaques in the Cerebellum and Corpus Striatum in Down's Syndrome Contain Amyloid β Protein (Aβ) only in the Form of Aβ42(43) , 1996 .

[79]  A. Odaka,et al.  Amyloid β protein 1–42/43 (Aβ 1–42/43) in cerebellar diffuse plaques: enzyme-linked immunosorbent assay and immunocytochemical study , 1995, Brain Research.

[80]  B. Crain,et al.  Interlaboratory Comparison of Neuropathology Assessments in Alzheimer's Disease: A Study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1994, Journal of neuropathology and experimental neurology.

[81]  John Q. Trojanowski,et al.  Amyloid plaques in cerebellar cortex and the integrity of Purkinje cell dendrites , 1994, Neurobiology of Aging.

[82]  M J Ball,et al.  beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[83]  M. Roth,et al.  Biochemical and anatomical redistribution of tau protein in Alzheimer's disease. , 1993, The American journal of pathology.

[84]  H. Braak,et al.  Alzheimer's disease: amyloid plaques in the cerebellum , 1989, Journal of the Neurological Sciences.

[85]  D. Selkoe,et al.  Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. , 1989, The American journal of pathology.

[86]  G. Cole,et al.  Amyloid plaques in the cerebellum in Alzheimer's disease. , 1989, Clinical neuropathology.

[87]  W. Poon,et al.  Caspase-cleaved glial fibrillary acidic protein within cerebellar white matter of the Alzheimer's disease brain. , 2013, International journal of clinical and experimental pathology.

[88]  A. Rajput,et al.  Defective dentate nucleus GABA receptors in essential tremor. , 2012, Brain : a journal of neurology.

[89]  A. Rajput,et al.  Cerebellar Purkinje cell loss is not pathognomonic of essential tremor. , 2011, Parkinsonism & related disorders.

[90]  D. Bennett,et al.  Biochemical Characterization of Aβ and Tau Pathologies in Mild Cognitive Impairment and Alzheimer's Disease , 2007 .

[91]  S. Hirai,et al.  Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated byβ protein immunostain , 2004, Acta Neuropathologica.

[92]  D. Mann,et al.  The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease , 2004, Acta Neuropathologica.

[93]  B. Jasani,et al.  The distribution of amyloid plaques in the cerebellum and brain stem in Down's syndrome and Alzheimer's disease: a light microscopical analysis , 2004, Acta Neuropathologica.

[94]  K. Jellinger.  Distribution of amyloid plaques in the cerebellum in Alzheimer's disease , 2004, Acta Neuropathologica.

[95]  R. Martins,et al.  The severity of cortical Alzheimer's type changes is positively correlated with increased amyloid-beta Levels: Resolubilization of amyloid-beta with transition metal ion chelators. , 2001, Journal of Alzheimer's disease : JAD.

[96]  D. Mann,et al.  Atypical amyloid (Aβ) deposition in the cerebellum in Alzheimer’s disease: an immunohistochemical study using end-specific Aβ monoclonal antibodies , 1996, Acta Neuropathologica.

[97]  M. Kirkitadze,et al.  Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways , 2002, Proceedings of the National Academy of Sciences of the United States of America.